Identify Individuals with Diabetes Who Are at Greater Risk of Heart Disease and Stroke by Utilizing MyHap2™

 

The management of Diabetes patients specific to the morbidity and mortality associated with cardiovascular disease and stroke is a priority for health care providers.

  • Haptoglobin is consistently associated as a marker in risk factor for cardiovascular disease.¹

  • Studies have shown that patients suffering from diabetes with two copies of the haptoglobin 2 variant are at a 5 times greater risk of heart attack and stroke

  • MyHap2™ is a proprietary genetic test for Haptoglobin 1/2, People with a personal or family history of diabetes should be tested to evaluate their risk. 

  • Order MyHap2™ to identify your diabetic patients with the highest risk of cardiovascular disease and stroke.

 
AdobeStock_122958843.jpg

MyHap2™ Genotype Report:

• Cardiovascular Risk Level

• Interpretation of Risk 

• Treatment Considerations 

 

References:
¹ Cahill LE et al. The risk of coronary heart disease associated with glycosylated hemoglobin of 6.5% or greater is pronounced in the Haptoglobin 2-2 genotype. JAM Coll Cardiol. 2015 Oct20:66(16):1791-1799.
https://www.ncbi.nlm.nih.gov/pubmed/26483103